Business case: Investing in production of High-Quality Magnesium Sulfate for Low-Resource Settings 26-03-2015
This report by the Reproductive Health Supplies Coalition provides the business case for investing in high-quality magnesium sulfate in low-resource settings. The magnesium sulfate business case is one of a three-part series focused on maternal health products that also includes business cases on the markets for misoprostol and oxytocin. Together, these three maternal health drugs are very effective at preventing maternal deaths, but there are problems with ensuring a reliable supply of high-quality, affordable products for countries
to procure. Jhpiego aims to increase the availability and appropriate use of these products.